Invention Grant
- Patent Title: CDK inhibitors
-
Application No.: US16226430Application Date: 2018-12-19
-
Publication No.: US10696682B2Publication Date: 2020-06-30
- Inventor: Francis X. Tavares , Jay Copeland Strum
- Applicant: G1 Therapeutics, Inc.
- Applicant Address: US NC Research Triangle Park
- Assignee: G1 Therapeutics, Inc.
- Current Assignee: G1 Therapeutics, Inc.
- Current Assignee Address: US NC Research Triangle Park
- Agency: Knowles Intellectual Property Strategies, LLC
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D487/14 ; C07D487/20 ; A61K31/499 ; C07D498/14 ; C07D519/00
Abstract:
Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
Public/Granted literature
- US20190119292A1 CDK INHIBITORS Public/Granted day:2019-04-25
Information query
IPC分类:
